tirzepatide logo mounjaro-logo-425px Mounjaro® (tirzepatide) injection and Zepbound®
Description
Nausea affects up to 29% of participants at higher doses
MTC, medullary thyroid cancer
Zepbound) gives the best effects
Mounjaro (tirzepatide) Injection, for subcutaneous use
Mg Units (40 mg vial + 2.0 mL BAC water = 20 mg/mL) Weekly dose 2.5 mg Volume 0.125 mL U-100 syringe units 12.5 units Weekly dose 5 mg Volume 0.25 mL U-100 syringe units 25 units Weekly dose 7.5 mg Volume 0.375 mL U-100 syringe units 37.5 units Weekly dose 10 mg Volume 0.50 mL U-100 syringe units 50 units Weekly dose 12.5 mg Volume 0.625 mL U-100 syringe units 62.5 units Weekly dose 15 mg Volume 0.75 mL U-100 syringe units 75 units On a 0.5 mL / 50-unit syringe, 12.5 mg and 15 mg need a larger syringe
Protein powder works best post-meal or as a mini-meal rather than on an empty stomach, which can trigger nausea in tirzepatide users
